Patents by Inventor Michael S. Malamas

Michael S. Malamas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040147755
    Abstract: This invention provides compounds of Formula I having the structure 1
    Type: Application
    Filed: January 8, 2004
    Publication date: July 29, 2004
    Applicant: Wyeth
    Inventor: Michael S. Malamas
  • Publication number: 20040102480
    Abstract: This invention provides compounds of Formula I having the structure 1
    Type: Application
    Filed: November 21, 2002
    Publication date: May 27, 2004
    Applicant: Wyeth
    Inventors: Michael S. Malamas, Jay E. Wrobel, Arlene J. Dietrich, Zenan Li, Iwan Gunawan
  • Patent number: 6699896
    Abstract: This invention provides compounds having the structure wherein A is OR5, or R1 is alkyl, cycloalkyl of 3-8 carbon atoms, thienyl, furyl, pyridyl, R2 is H, alkyl, or aryl; R3 and R4 are halo, H, alkyl, aryl, trifluoromethyl, alkoxyaryl, nitro, amino, carboalkoxy, carbamide, carbamate, urea, alkylsulfonamide, —NR7(CH2)mCO2H, arylsulfonamide, cycloalkyl, or a heterocycle; R5 is H, alkyl, —CH(R8)R9, —CH2(CH2)nCO2R10, —C(CH3)2CO2R10, —CH(R8)(CH2)nCO2R10, —CH(R8)C6H4CO2R10, or —CH2-tetrazole; R6 is H, alkyl, halo, alkoxy, trifluoroalkyl or trifluoroalkoxy; R7 is H or alkyl; R8 is H, alkyl, aryl, arylalkyl, cycloalkyl, phthalic acid, R9 is CO2R12, CONHR12, tetrazole, or PO3R12; R10 is H, alkyl, aryl, or aralkyl; R11 is alkyl; R12 is H, alkyl, aryl, or aralkyl; X is O, or S; Y is O, N, or S; Z is C, or N; Q is O, N, or S; m=1-3; n=1-6, or a pharmaceutically acceptable salt thereof, which
    Type: Grant
    Filed: May 10, 1999
    Date of Patent: March 2, 2004
    Assignee: Wyeth
    Inventor: Michael S. Malamas
  • Publication number: 20030207927
    Abstract: This invention provides estrogen receptor modulators of formula I, having the structure 1
    Type: Application
    Filed: December 11, 2002
    Publication date: November 6, 2003
    Applicant: Wyeth
    Inventors: Michael S. Malamas, Tam Q. Dinh, Iwan Gunawan, Michael D. Collini, Heather A. Harris, James C. Keith, Leo M. Albert
  • Publication number: 20030199562
    Abstract: This invention provides estrogen receptor modulators of formula I, having the structure 1
    Type: Application
    Filed: December 4, 2002
    Publication date: October 23, 2003
    Applicant: Wyeth
    Inventors: Michael S. Malamas, Robert E. McDevitt, Iwan Gunawan, Eric S. Manas, Michael D. Collini, Heather A. Harris, James C. Keith, Leo M. Albert, C. Richard Lyttle
  • Publication number: 20030171412
    Abstract: This invention provides estrogen receptor modulators of formula 1, having the structure 1
    Type: Application
    Filed: December 11, 2002
    Publication date: September 11, 2003
    Applicant: Wyeth
    Inventors: Michael S. Malamas, Iwan Gunawan, Heather A. Harris, James C. Keith, Leo M. Albert
  • Patent number: 6525202
    Abstract: This invention provides compounds of Formula I having the structure wherein, R1, R2, R3, R4, R5, T, T1, T2, and X are as defined hereinbefore, or a pharmaceutically acceptable salt thereof, which are useful in treating or inhibiting metabolic disorders related to insulin resistance or hyperglycemia (typically associated with obesity or glucose intolerance), atherosclerosis, gastrointestinal disorders, neurogenetic inflammation, glaucoma, ocular hypertension and frequent urination; and are particularly useful in the treatment or inhibition of type II diabetes.
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: February 25, 2003
    Assignee: Wyeth
    Inventors: Baihua Hu, Fuk-Wah Sum, Michael S. Malamas
  • Patent number: 6509360
    Abstract: This invention provides compounds of Formula I having the structure wherein: A, B, R1, R2, R3, R4, R5, and R6 are as defined in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
    Type: Grant
    Filed: August 11, 2000
    Date of Patent: January 21, 2003
    Assignee: Wyeth
    Inventors: Michael S. Malamas, Jay E. Wrobel, Arlene J. Dietrich, Zenan Li, Iwan Gunawan
  • Patent number: 6391897
    Abstract: This invention provides substituted compounds of the general formulae: wherein B and E are C or N; D, G and W are O, S, or N; or salt forms thereof, and methods and pharmaceutical compositions for their use in treating disorders related to insulin resistance or hyperglycemia.
    Type: Grant
    Filed: March 2, 2001
    Date of Patent: May 21, 2002
    Assignee: American Home Products Corporation
    Inventors: Michael S. Malamas, Robert E. McDevitt, Folake O. Adebayo
  • Patent number: 6369072
    Abstract: This invention provides substituted compounds of the general formulae: wherein B and E are C or N; D, G and W are O, S, or N; or salt forms thereof, and methods and pharmaceutical compositions for their use in treating disorders related to insulin resistance or hyperglycemia.
    Type: Grant
    Filed: March 2, 2001
    Date of Patent: April 9, 2002
    Assignee: American Home Products Corporation
    Inventors: Michael S. Malamas, Robert E. McDevitt, Folake O. Adebayo
  • Publication number: 20020032222
    Abstract: This invention provides compounds of Formula I having the structure 1
    Type: Application
    Filed: July 12, 2001
    Publication date: March 14, 2002
    Applicant: American Home Products Corporation
    Inventors: Michael S. Malamas, Elwood E. Largis, Iwan Gunawan, Zenan Li
  • Publication number: 20020028797
    Abstract: This invention provides compounds of Formula I having the structure 1
    Type: Application
    Filed: July 12, 2001
    Publication date: March 7, 2002
    Applicant: American Home Products Corporation
    Inventors: Fuk-Wah Sum, Michael S. Malamas
  • Publication number: 20020028835
    Abstract: This invention provides compounds of Formula I having the structure 1
    Type: Application
    Filed: July 12, 2001
    Publication date: March 7, 2002
    Inventors: Baihua Hu, Fuk-Wah Sum, Michael S Malamas
  • Publication number: 20010053785
    Abstract: This invention provides substituted compounds of the general formulae: 1
    Type: Application
    Filed: March 2, 2001
    Publication date: December 20, 2001
    Inventors: Michael S. Malamas, Richard E. McDevitt, Folake O. Adebayo
  • Publication number: 20010041715
    Abstract: This invention provides substituted compounds of the general formulae: 1
    Type: Application
    Filed: March 2, 2001
    Publication date: November 15, 2001
    Inventors: Michael S. Malamas, Richard E. McDevitt, Folake O. Adebayo
  • Patent number: 6310081
    Abstract: This invention provides compounds of Formula I having the structure wherein A, Q, R3, and R4 are as defined hereinbefore in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
    Type: Grant
    Filed: March 1, 2001
    Date of Patent: October 30, 2001
    Assignee: American Home Products Corporation
    Inventors: Michael S. Malamas, Folake O. Adebayo, Paul J. Dollings
  • Patent number: 6232322
    Abstract: This invention provides compounds of Formula I having the structure wherein A, R3, R4, and R5 are as defined hereinbefore in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
    Type: Grant
    Filed: May 10, 1999
    Date of Patent: May 15, 2001
    Assignee: American Home Products Corporation
    Inventors: Michael S. Malamas, Robert E. McDevitt, Folake O. Adebayo
  • Patent number: 6221902
    Abstract: This invention provides compounds of Formula I having the structure wherein A, Q, R3, and R4 are as defined hereinbefore in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
    Type: Grant
    Filed: May 10, 1999
    Date of Patent: April 24, 2001
    Assignee: American Home Products Corporation
    Inventors: Michael S. Malamas, Folake O. Adebayo, Paul J. Dollings
  • Patent number: 6214842
    Abstract: This invention provides compounds of Formula I having the structure wherein: R is hydrogen or alkyl of 1-6 carbon atoms; A is R1, R2, R3 are each, independently, hydrogen, alkoxy of 1-6 carbon atoms, thioalkyl of 1-6 carbon atoms, trifluoromethyl, R4 is hydrogen, alkyl of 1-6 carbon atoms, halogen, or alkoxy of 1-6 carbon atoms; R5 is phenyl, naphthyl, thienyl, furyl, wherein R5 may be optionally mono-, di-, or tri-substituted with a sustituent selected from the group consisting of alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, trifluoromethyl, halogen, alkoxycarbonyl of 2-7 carbon atoms, alkylamino of 1-6 carbon atoms, and dialkylamino in which each of the alkyl groups is of 1-6 carbon atoms, nitro, cyano, —CO2H, alkylcarbonyloxy of 2-7 carbon atoms, and alkylcarbonyl of 2-7 carbon atoms; m=1-4; n=1-4; and X=O, S, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders relat
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: April 10, 2001
    Inventors: Michael S. Malamas, Iwan Gunawan
  • Patent number: 6166069
    Abstract: This invention provides compounds of Formula I having the structure ##STR1## wherein: A, B, R1, R2, R3, R4, R5, and R6 are as defined in the specification,or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
    Type: Grant
    Filed: May 10, 1999
    Date of Patent: December 26, 2000
    Assignee: American Home Products Corporation
    Inventors: Michael S. Malamas, Jay E. Wrobel, Arlene J. Dietrich, Zenan Li, Iwan Gunawan